In Silico Docking of Lariciresinol: Implications for Attenuating LPS-induced Acute Lung Injury via TLR4/MyD88/NF-κB Inhibition
Lariciresinol effectively attenuated LPS-induced ALI in mice by suppressing inflammatory responses through the downregulation of the TLR4/MyD88/NF-κB signaling pathway and suggesting that lariciresinol may serve as a promising therapeutic candidate for the management of ALI owing to its potent anti-inflammatory activit...